The Spectrum of Myeloproliferative Disorders (Q39924437)

15 September 2017

1 reference

title

The Spectrum of Myeloproliferative Disorders (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

6 February 2023

author name string

H. S. Gilbert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4570933

6 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4570933

6 February 2023

publication date

1 March 1973

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:S0025712516322878?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

https://api.elsevier.com/content/article/PII:S0025712516322878?httpAccept=text/plain

6 February 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

Medical Clinics of North America

6 February 2023

published in

1 reference

15 September 2017

volume

57

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

355-393

1 reference

A study of the defects in the blood coagulation mechanisms in polycythemia vera

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

"Gaucher cells" in chronic myeloic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

LEUKOKINETIC STUDIES. X. BLOOD GRANULOCYTE KINETICS IN CHRONIC MYELOCYTIC LEUKEMIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

THE EFFECT OF TREATMENT IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. BIOCHEMICAL STUDIES

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Blood Volume Studies in Patients with Splenomegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Plasma volume and splenomegaly in polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Spurious (relative) polycythemia: A nonexistent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

THE EFFECT OF TREATMENT IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA. HEMATOLOGIC AND CYTOGENETIC STUDIES

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Complications and causes of death in polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Involvement of the erythroid series in blastic crisis of chronic myeloid leukaemia. Further evidence for the presence of Philadelphia chromosome in erythroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Acquired pseudo-Pelger anomaly of granulocytic leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

SPLENECTOMY FOR AGNOGENIC MYELOID METAPLASIA AND MYELOFIBROSIS

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Enzyme Abnormality in Human Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Serum vitamin B12 content and unsaturated vitamin B12-binding capacity in myeloproliferative disease. Value in differential diagnosis and as indicators of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Transitions among the myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Haemorrhagic thrombocythaemia: a clinical and laboratory study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Thrombokinetics in man

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

SPLENECTOMY IN MYELOFIBROSIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Comparison of busulfan and cyclophosphamide in the treatment of chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Metastatic carcinoma simulating agnogenic myeloid metaplasia and myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Marrow studies with radiocolloids

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

COMPARISON OF PHILADELPHIA CHROMOSOME-POSITIVE AND-NEGATIVE PATIENTS WITH CHRONIC MYELOCYTIC LEUKEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Is primary hemorrhagic thrombocythemia a clinical myth?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Platelet function tests in thrombocythaemia and thrombocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

THYMIDINE CATABOLISM BY NORMAL AND LEUKEMIC HUMAN LEUKOCYTES.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

A Diagnostic Test for Chronic Myelogenous Leukemia Based on Abnormalities of B12‐binding

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

POLYCYTHEMIA VERA AND LEUKEMIA--THE ROLE OF RADIATION TREATMENT. A STUDY OF 1222 PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Myeloid megakaryocytic hepatosplenomegaly. Case study with a proposed system of matrix classification of the myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Primary hemorrhagic thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Influence of Hyperdiploidy on Ph1 Prevalence Response to Therapy in Chronic Myelogenous Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Cellular changes in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Relation between phagocytic activity and alkaline phosphatase content of neutrophils in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

The haematological and histological findings in 18 patients with clinical features resembling those of myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

The local exudative cellular response in leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Correlation of Radiologic, Histologic, and Clinical Findings in Agnogenic Myeloid Metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Studies of Splenic Function in the Myeloproliferative Disorders and Generalized Malignant Lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

A clinical and pathological study of seventy cases of myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Direct evidence for presence of Ph-1 chromosome in erythroid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Allopurinol in the Treatment of Gout

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

A CLINICAL STUDY OF TWENTY CASES OF ERYTHROLEUKEMIA (DI GUGLIELMO'S SYNDROME)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Myelocytic leukemia: an analysis of incidence, distribution and fatality, 1910-1948

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

STUDIES ON NORMAL AND LEUKEMIC LEUKOCYTES. VI. THYMIDYLATE SYNTHETASE AND DEOXYCYTIDYLATE DEAMINASE

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Primary or hemorrhagic thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Hemorrhagic thrombocythemia; a blood coagulation disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Defective Platelets in Essential Thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

A direct measurement of the radiation sensitivity of normal mouse bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Polycythaemia vera. Course and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

Secondary gout associated with myeloproliferative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932287-8

7 January 2021

The activated phagocyte of polycythemia vera

24

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

Foreword and a proposal for considering paroxysmal nocturnal hemoglobinuria (PNH) as a "candidate" myeloproliferative disorder

6 February 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

Increased transcobalamin I in a leukemoid reaction

6 February 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

Platelet function in health and disease

6 February 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

Response of polycythemia vera marrow to erythropoietin in vitro

6 February 2023

66

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

Serum transcobalamin in myeloid leukemia

6 February 2023

93

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

Causes of death in agnogenic myeloid metaplasia

6 February 2023

107

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

Markedly increased bone blood flow in myelofibrosis

6 February 2023

113

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

Alkaline phosphatase activity in normal and abnormal human blood and bone marrow cells

6 February 2023

117

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32287-8

6 February 2023

Identifiers

0 references

1 reference